What the six lenses say about WOCKPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How WOCKPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +6.2pp | +18.5pp | +15.3pp | +13.8pp | +72.6pp | +55.2pp |
Nifty 500 Broad-market baseline | +6.1pp | +18.5pp | +14.2pp | +12.2pp | +66.9pp | +50.0pp |
Sector Own-sector index | — | — | +11.4pp | +6.2pp | +53.8pp | +29.2pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
WOCKPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
WOCKPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 739 | 809 | 721 | 743 | 738 | 782 | 888 | 965 |
| ↳ change QoQ | — | +9.5% | -10.9% | +3.1% | -0.7% | +6.0% | +13.6% | +8.7% |
| EBITDA (₹cr) | 121 | 119 | 136 | 64 | 72 | 178 | 177 | 225 |
| EBITDA margin | 16.4% | 14.7% | 18.9% | 8.6% | 9.8% | 22.8% | 19.9% | 23.3% |
| PAT (₹cr) | -16 | -16 | 20 | -45 | -108 | 82 | 61 | 164 |
| ↳ change QoQ | — | +0.0% | +225.0% | -325.0% | -140.0% | +175.9% | -25.6% | +168.9% |
| Net margin | -2.2% | -2.0% | 2.8% | -6.1% | -14.6% | 10.5% | 6.9% | 17.0% |
| EPS (₹) | -0.95 | -1.47 | 0.91 | -1.54 | -5.54 | 4.80 | 3.63 | 10.22 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding WOCKPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Mirae Asset ELSS Tax Saver Reg Gr | 0.64% | 26,373 | |
| HSBC Small Cap Fund Reg Gr | 1.30% | 17,784 | |
| Tata Small Cap Fund Reg Gr | 3.24% | 12,696 | |
| Tata Large & Mid Cap Reg Gr | 2.43% | 7,901 | |
| HSBC Flexi Cap Gr | 1.23% | 5,718 | |
| HSBC Aggressive Hybrid Gr | 0.69% | 5,691 | |
| Tata Multi Asset Allocation Reg Gr | 0.73% | 5,234 | |
| Mirae Asset Small Cap Reg Gr | 0.76% | 5,221 | |
| ITI Small Cap Reg Gr | 1.79% | 3,454 | |
| HDFC Pharma and Healthcare Reg Gr | 1.89% | 2,940 |
ETFs holding WOCKPHARMA (9)